Crinetics Pharmaceuticals, Inc. (CRNX)
47.40
+0.73
(+1.56%)
USD |
NASDAQ |
Dec 08, 16:00
47.41
+0.01
(+0.02%)
Pre-Market: 20:00
Crinetics Pharmaceuticals Total Liabilities (Quarterly): 123.86M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 91.08B |
| Amgen, Inc. | 80.52B |
| Madrigal Pharmaceuticals, Inc. | 736.72M |
| United Therapeutics Corp. | 760.90M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.196B |
| Shareholders Equity (Quarterly) | 1.072B |
| Debt to Equity Ratio | 0.0458 |
| Current Ratio | 15.12 |
| Net Debt Paydown Yield | 0.02% |